AGIOS PHARMACEUTICALS, INC. — Form 4
Filed October 28, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 49/100
What the filing says
Chief Medical Officer Gheuens Sarah (AGIO) sold 16K shares (~$296K) on the open market (49% of holdings). Large sale — ~49% of holdings.
Why this rating
Large sale — ~49% of holdings.
See more from October 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.